Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating a monoclonal antibody therapy in colorectal cancer, including metastatic disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colorectal Cancer

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED